Page 1,222«..1020..1,2211,2221,2231,224..1,2301,240..»

Tokyo’s Heartseed reaps $26M to test its stem cell injections for heart failure – FierceBiotech

Posted: Published on November 25th, 2019

Tokyo-based Heartseed has raised 2.8 billion yen, or about $26 million U.S., to help develop its stem cell-based treatment for heart failure. The company has its eyes on two clinical trials, set to start in the next year: an investigator-initiated study through its research partner Keio University in dilated cardiomyopathy, followed by a phase 1/2 trial in late 2020 for heart failure with reduced left ventricular ejection fraction. Continue reading →

Posted in Stem Cell Research | Comments Off on Tokyo’s Heartseed reaps $26M to test its stem cell injections for heart failure – FierceBiotech

Partnership aims to accelerate cell and gene therapy – Harvard Gazette

Posted: Published on November 25th, 2019

MIT Provost Martin A. Schmidt said sharing the risk among several institutions will not only make possible work that would be difficult for a single institution to tackle, it will also encourage collaboration that accelerates the process of moving discoveries from lab to patient Continue reading →

Posted in Stem Cell Research | Comments Off on Partnership aims to accelerate cell and gene therapy – Harvard Gazette

New Device Permits a Closer Look at Previously Inaccessible Areas of the Genome – Technology Networks

Posted: Published on November 25th, 2019

The sequencing device has tiny nanopores that can determine both the DNA sequence and the epigenetic signature. Credit: MPI f. Molecular Genetics/ Pay Gieelmann. Continue reading →

Posted in Stem Cell Research | Comments Off on New Device Permits a Closer Look at Previously Inaccessible Areas of the Genome – Technology Networks

Research Antibodies and Reagents Market Worth $14.56 Billion by 2025 – Exclusive Report by Meticulous Research – GlobeNewswire

Posted: Published on November 25th, 2019

November 25, 2019 06:54 ET | Source: Meticulous Market Research Pvt. Ltd. London, Nov Continue reading →

Posted in Stem Cell Research | Comments Off on Research Antibodies and Reagents Market Worth $14.56 Billion by 2025 – Exclusive Report by Meticulous Research – GlobeNewswire

Decoding the building blocks of life: bit bio races toward a sustainable source of human cells – Proactive Investors UK

Posted: Published on November 25th, 2019

The ability to turn human cells into anything we want sounds like the stuff of science fiction. But one Cambridge biotech says it's cracked the code A sustainable source of human stem cells is one of the holy grails of modern medicine. With applications as broad as re-growing failed organs, fighting cancer, and stopping animal testing, stem cell therapy is predicted to be worth US$35bn by 2023 Continue reading →

Posted in Stem Cell Research | Comments Off on Decoding the building blocks of life: bit bio races toward a sustainable source of human cells – Proactive Investors UK

Elbasvir/grazoprevir in women with hepatitis C virus infection taking | IJWH – Dove Medical Press

Posted: Published on November 24th, 2019

Christophe Hzode,1 Paul Kwo,2 Jan Sperl,3 Peggy Hwang,4 Jianmin Long,4 Rohit Talwani,4 Michael N Robertson,4 Barbara A Haber4 1Service dHpatologie, Hpital Henri-Mondor, AP-HP, Universit Paris-Est, INSERM U955, Crteil, France; 2Division of Gastroenterology/Hepatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA; 3Department of Hepatogastroenterology, Institut Klinick a Experimentln Medicny (IKEM), Prague, Czech Republic; 4Department of Infectious Disease, Merck & Co., Inc., Kenilworth, NJ, USA Correspondence: Christophe Hzode Service dHepatologie, Hpital Henri Mondor, 51, avenue du Marchal de Lattre de Tassigny, Crteil 94010, France Tel +33 14 981 2111 Email christophe.hezode@aphp.fr Introduction: Some direct-acting antiviral regimens for hepatitis C virus (HCV) infection pose safety or efficacy concerns if coadministered with drugs containing ethinyl estradiol. The present analysis was conducted to examine the impact of concomitant oral contraceptive pills (OCP) or hormone replacement therapy (HRT) during treatment with elbasvir (EBR)/grazoprevir (GZR) in women with HCV genotype (GT)1 or GT4 infection. Methods: This is a post hoc, integrated retrospective analysis of female participants with HCV GT1 or GT4 infection who received EBR 50mg/GZR 100mg once daily for 12weeks in phase 2/3 clinical trials. Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Elbasvir/grazoprevir in women with hepatitis C virus infection taking | IJWH – Dove Medical Press

Hormone Replacement Therapy Market Overview With Demographic Data And Industry Growth, Latest Trends,Forecast 2019-2026 – Alpha News Report

Posted: Published on November 24th, 2019

This extensive analysis sheds light on an array of intangible aspects connected with the business such as important definitions, end use and total revenue garnered across different regions. The researcher has taken a conscious effort to get a closer look at some of the top performers of the Hormone Replacement Therapy industry. Other essential aspects evaluated during research include import and export, demand and supply, distribution channel, gross margin and supply chain management Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Hormone Replacement Therapy Market Overview With Demographic Data And Industry Growth, Latest Trends,Forecast 2019-2026 – Alpha News Report

The Women’s Health Issue That’s Finally Starting to Get Recognition – Worth

Posted: Published on November 24th, 2019

Long overlooked, menopause starts to get noticed as doctors and entrepreneurs see a market ripe for disruption. Women are desperate to figure out why they dont feel good. Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on The Women’s Health Issue That’s Finally Starting to Get Recognition – Worth

Global Hormone Replacement Therapy Market Growth Driver 2016 2024: By Companies Pfizer, BioSante Pharmaceuticals and Amgen, Noven Pharmaceuticals,…

Posted: Published on November 24th, 2019

A leading research firm, Zion Market Research added a latest industry report on "Global Hormone Replacement Therapy Market" consisting of 110+ pages during the forecast period and Hormone Replacement Therapy Market report offers a comprehensive research updates and information related to market growth, demand, opportunities in the global Hormone Replacement Therapy Market. According to the report the Global Hormone Replacement Therapy Market Growth Driver 2016 2024: By Pfizer, BioSante Pharmaceuticals and Amgen, Noven Pharmaceuticals, Bayer AG, Merck & co., and QuatRx Pharmaceuticals. Pfizer, BioSante Pharmaceuticals and Amgen, Noven Pharmaceuticals, Bayer AG The Hormone Replacement Therapy Market report provides in-depth analysis and insights into developments impacting businesses and enterprises on global and regional level. Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Global Hormone Replacement Therapy Market Growth Driver 2016 2024: By Companies Pfizer, BioSante Pharmaceuticals and Amgen, Noven Pharmaceuticals,…

Making sense of menopausal hormone therapy – Monash Lens – Monash Lens

Posted: Published on November 24th, 2019

At menopause, a womans ovaries lose their reproductive function. Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Making sense of menopausal hormone therapy – Monash Lens – Monash Lens

Page 1,222«..1020..1,2211,2221,2231,224..1,2301,240..»